loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 210045 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Purple Biotech

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 PURPLE BIOTECH (3)

    filter

    01 TABLET;ORAL (3)

    filter

    01 DISCN (3)

    filter

    01 CONSENSI (3)

    filter

    01 Yes (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Israel
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      AMLODIPINE BESYLATE; CELECOXIB

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET; ORAL
      EQ 10MG BASE;200MG
      2018-05-31
      210045
      CONSENSI
      DISCN
      Yes
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag Israel
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        AMLODIPINE BESYLATE; CELECOXIB

        PDF Supplier PDF
        URL Supplier Web Content
        TABLET; ORAL
        EQ 2.5MG BASE;200M...
        2018-05-31
        210045
        CONSENSI
        DISCN
        Yes
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag Israel
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          AMLODIPINE BESYLATE; CELECOXIB

          PDF Supplier PDF
          URL Supplier Web Content
          TABLET; ORAL
          EQ 5MG BASE;200MG
          2018-05-31
          210045
          CONSENSI
          DISCN
          Yes
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Looking for FDA Orange Book APPLICATION 210045

          Looking for FDA Orange Book APPLICATION 210045 3

          19

          Purple Biotech, based in Israel, is a pharmaceutical company.

          One of their notable products is AMLODIPINE BESYLATE; CELECOXIB, with a corresponding application number 210045.

          Regulatory Information DISCN

          With a dosage strength EQ 10MG BASE;200MG

          Dosage Form Route TABLET; ORAL

          Reference Listed Drug Yes

          Approved since 2018-05-31

          18

          Purple Biotech, based in Israel, is a pharmaceutical company.

          One of their notable products is AMLODIPINE BESYLATE; CELECOXIB, with a corresponding application number 210045.

          Regulatory Information DISCN

          With a dosage strength EQ 2.5MG BASE;200MG

          Dosage Form Route TABLET; ORAL

          Reference Listed Drug Yes

          Approved since 2018-05-31

          17

          Purple Biotech, based in Israel, is a pharmaceutical company.

          One of their notable products is AMLODIPINE BESYLATE; CELECOXIB, with a corresponding application number 210045.

          Regulatory Information DISCN

          With a dosage strength EQ 5MG BASE;200MG

          Dosage Form Route TABLET; ORAL

          Reference Listed Drug Yes

          Approved since 2018-05-31

          Post Enquiry
          POST ENQUIRY